Anhui Meiluo Pharmaceutical Technology Co., Ltd., formerly known as Changzhou Audi Chemical Technology Co., Ltd., is a technology-driven enterprise dedicated to the research and development of pharmaceutical intermediates, particularly the customization and production of fluorinated heterocyclic pharmaceutical intermediates. To better serve its customers, the company established Anhui Meiluo Pharmaceutical Technology Co., Ltd. in 2021 at the Ningma Science and Technology Innovation Park in Cihu High-Tech Zone, Ma'anshan, Anhui Province, where it built a 2,600-square-meter R&D center.

The company employs doctors, masters, and well-trained chemical technicians with years of experience in organic synthesis, forming a young, excellent, cohesive, and creative team. It also collaborates with pharmaceutical and chemical enterprises in Shijiazhuang, Xuchang, and Yantai to jointly establish pilot and scale-up workshops. The company specializes in various reaction types such as halogenation, hydrogenation, nitration, condensation, oxidation, and reduction. It maintains strong technical collaborations with East China Normal University, Changzhou University, and the School of Pharmacy of Wannan Medical College, demonstrating robust capabilities in new product development.

The company has provided over a thousand customized compounds for customers, primarily supplying major pharmaceutical and pesticide manufacturers, as well as research institutions both domestically and internationally. Its products are exported to the United States, Europe, Japan, India, and other countries and regions. The company can offer customized production from laboratory-scale gram-level orders to commercial ton-level large-scale production based on customer needs.